BIO
Bio-Rad Laboratories IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$7.65B
P/E Ratio
47.66
EPS
$6.00
Beta
1.08
52W High
$343.12
52W Low
$222.80
50-Day MA
$282.83
200-Day MA
$293.87
Dividend Yield
—
Profit Margin
6.52%
Forward P/E
33.11
PEG Ratio
1.19
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Fundamentals
| Revenue (TTM) | $2.59B |
| Gross Profit (TTM) | $1.35B |
| EBITDA | $444.80M |
| Operating Margin | 5.76% |
| Return on Equity | 2.50% |
| Return on Assets | 1.79% |
| Revenue/Share (TTM) | $95.80 |
| Book Value | $255.37 |
| Price-to-Book | 1.14 |
| Price-to-Sales (TTM) | 2.96 |
| EV/Revenue | 2.973 |
| EV/EBITDA | 17.51 |
| Quarterly Earnings Growth (YoY) | -83.00% |
| Quarterly Revenue Growth (YoY) | 1.10% |
| Shares Outstanding | $21.70M |
| Float | $20.91M |
| % Insiders | 16.34% |
| % Institutions | 94.40% |
Historical Volatility
HV 10-Day
29.96%
HV 20-Day
56.60%
HV 30-Day
55.38%
HV 60-Day
45.62%
HV Rank
82.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($297.00 target)
4
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026